Current status and progress of left ventricular assist device for end-stage heart failure
- VernacularTitle:左心室辅助装置治疗心力衰竭的现状及进展
- Author:
Li YUAN
1
;
Xiaoning SUN
1
;
Chunsheng WANG
1
Author Information
1. Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China
- Publication Type:Journal Article
- Keywords:
Left ventricular assist device;
heart failure;
mechanical circulatory support;
review
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2022;29(04):508-513
- CountryChina
- Language:Chinese
-
Abstract:
Although heart transplantation remains to be the optimal treatment for advanced heart failure, its use has been largely limited due to shortage of available donor organs. Over the past two decades, left ventricular assist device (LVAD) has been significantly modified in size, durability and hemocompatibility. In addition to the bridge to transplantation, LVAD has become an attractive alternative to heart transplantation for end-stage heart failure as destination therapy for unsuitable candidates. Although the performance of LVAD has been improving greatly in recent years, there are still great challenges in the management of device complications and low quality of life after implantation. This review will summarize the types of LVAD, indications for implantation, postoperative management and adverse events.
